← Open Payments lookup

KATHLEEN LINKE: Open Payments

NPI 1265883649 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,180 in 93 payments from 16 companies in 2025. Trend: 2023 $1,919 · 2024 $1,732 · 2025 $2,180

Food & beverage: $2,126Education: $54
CompanyPaymentsAmount
ABBVIE INC.35$575
Madrigal Pharmaceuticals7$367
Janssen Biotech, Inc.12$278
PFIZER INC.8$199
Takeda Pharmaceuticals U.S.A., Inc.7$158
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$113
Gilead Sciences, Inc.4$97
Enterra Medical, Inc.1$81
Phathom Pharmaceuticals, Inc.3$63
VIVUS LLC3$57

Products named: REZDIFFRA, TREMFYA, RINVOQ, SKYRIZI, XELJANZ, ENTYVIO, XIFAXAN, DUPIXENT.

Industry payments across CA — which companies pay providers there.